Lycopodium (LYL) has a market capitalization of approximately A$736M, trading at A
Lycopodium's trailing twelve-month P/E ratio is 20.4x, with a price-to-book (P/B) of 4.6x. Valuation multiples are best compared with Industrials sector peers rather than read in isolation.
Lycopodium runs a net profit margin of 10.3%, a gross margin of 21.9%, and an operating margin of 13.5%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
Lycopodium reported revenue of A
Lycopodium offers a trailing dividend yield of about 2.5%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Lycopodium carries a debt-to-equity ratio of 0.17x and a current ratio of 2.30x, with a market beta of 0.16. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Lycopodium (LYL) the key facts are: market cap A$736M, P/E 20.4x, revenue A
Get Lycopodium's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.